ACHE and early-onset autosomal dominant Alzheimer disease: Inhibitors of AChE enzyme are clinically used in Alzheimer’s disease to improve memory and cognition and are the only approved agents by the FDA for the disease in addition to mementine-a glutmate receptor antagonist.